A detailed history of Bank Of America Corp transactions in Insmed Inc stock. As of the latest transaction made, Bank Of America Corp holds 1,119,208 shares of INSM stock, worth $81.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,119,208
Previous 996,128 12.36%
Holding current value
$81.6 Million
Previous $27 Million 177.48%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $2.71 Million - $8.58 Million
123,080 Added 12.36%
1,119,208 $75 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $1.23 Million - $1.43 Million
-47,703 Reduced 4.57%
996,128 $27 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $4.73 Million - $6.41 Million
201,819 Added 23.97%
1,043,831 $32.3 Million
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $2.34 Million - $3 Million
-142,408 Reduced 14.47%
842,012 $17.8 Million
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $4.84 Million - $6.47 Million
297,959 Added 43.41%
984,420 $16.8 Million
Q4 2022

Feb 10, 2023

BUY
$16.98 - $23.15 $1.61 Million - $2.19 Million
94,604 Added 15.98%
686,461 $13.7 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $1.04 Million - $1.4 Million
49,805 Added 9.19%
591,857 $12.7 Million
Q2 2022

Aug 12, 2022

SELL
$17.07 - $25.71 $820,486 - $1.24 Million
-48,066 Reduced 8.15%
542,052 $10.7 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $3.26 Million - $4.5 Million
159,845 Added 37.15%
590,118 $13.9 Million
Q4 2021

Feb 08, 2022

BUY
$25.89 - $33.45 $1.31 Million - $1.69 Million
50,458 Added 13.28%
430,273 $11.7 Million
Q3 2021

Nov 15, 2021

BUY
$22.46 - $29.47 $267,633 - $351,164
11,916 Added 3.24%
379,815 $10.5 Million
Q2 2021

Sep 13, 2021

BUY
$24.17 - $36.01 $8.89 Million - $13.2 Million
367,899 New
367,899 $10.5 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.88B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.